Treatment free remission in chronic myeloid leukemia: Lights and shadows

In addition to the best possible overall survival, discontinuation of the tyrosine kinase-inhibitor (TKI) treatment [treatment free remission (TFR)] without observing a recurrence of the disease has become a standard part of chronic myeloid leukemia (CML) care. Worldwide, more than 2000 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Molica, Matteo, Noguera, Nelida I., Trawinska, Malgorzata Monika, Martinelli, Giovanni, Cerchione, Claudio, Abruzzese, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2020
Materias:
How to manage - Chronic Myeloid Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520857/
https://www.ncbi.nlm.nih.gov/pubmed/33042501
http://dx.doi.org/10.4081/hr.2020.8950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520857/
https://www.ncbi.nlm.nih.gov/pubmed/33042501
http://dx.doi.org/10.4081/hr.2020.8950

Ejemplares similares